These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33779061)

  • 1. Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta-analyses.
    Rasmussen MLR; Schou MG; Bach-Holm D; Heegaard S; Jørgensen CAB; Kessel L; Wiencke AK; Subhi Y
    Acta Ophthalmol; 2022 Feb; 100(1):35-44. PubMed ID: 33779061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis.
    Roumeau I; Coutu A; Navel V; Pereira B; Baker JS; Chiambaretta F; Bremond-Gignac D; Dutheil F
    J Allergy Clin Immunol; 2021 Sep; 148(3):822-834. PubMed ID: 33819510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.
    Kim SE; Nowak V; Quartilho A; Larkin F; Hingorani M; Tuft S; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013298. PubMed ID: 33084033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.
    Mantelli F; Santos MS; Petitti T; Sgrulletta R; Cortes M; Lambiase A; Bonini S
    Br J Ophthalmol; 2007 Dec; 91(12):1656-61. PubMed ID: 17588996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK; Hasiripi H; Christen WG; Kalayci D
    Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH; Tabbara KF
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis.
    Verin PH; Dicker ID; Mortemousque B
    Clin Exp Allergy; 1999 Apr; 29(4):529-36. PubMed ID: 10202368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data.
    Swamy BN; Chilov M; McClellan K; Petsoglou C
    Ophthalmic Epidemiol; 2007; 14(5):311-9. PubMed ID: 17994441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.
    Lambiase A; Minchiotti S; Leonardi A; Secchi AG; Rolando M; Calabria G; Orsoni J; Zola E; Ferreri G; Aragona P; Reibaldi A; Chisari G; Bonini S
    Ophthalmic Epidemiol; 2009; 16(1):38-41. PubMed ID: 19191180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.